UPTIDE
← Research Database/← CJC-1295 with DAC/Endocrine Research

Prolonged stimulation of GH and IGF-I by CJC-1295

Limited Human2006human clinicalCJC-1295 with DAC →

Teichman et al. · PubMed

PubMed · PMID 16352683 DOI 10.1210/jc.2005-1536 Search PubMed Google Scholar
Abstract / Summary

Research demonstrates that CJC-1295 significantly elevates baseline and pulsatile GH and IGF-1 levels over an extended multiday observation period.

Methods

Investigated as a human clinical in the field of endocrine research. The study design follows the methodology described in the published manuscript indexed under the identifiers listed above. Full methodological detail is available in the source publication via the PubMed or DOI link.

Results

Research demonstrates that CJC-1295 significantly elevates baseline and pulsatile GH and IGF-1 levels over an extended multiday observation period.

Limitations

Studies primarily investigate pharmacokinetic markers rather than longitudinal safety or clinical efficacy.

External links